Manchikanti Laxmaiah, Knezevic Nebojsa Nick, Knezevic Emilija, Pasupuleti Rachana, Kaye Alan D, Sanapati Mahendra R, Hirsch Joshua A
Pain Management Centers of America, 67 Lakeview Drive, Paducah, KY, 42001, USA.
Pain Management Centers of America, Evansville, IN, USA.
Pain Ther. 2023 Aug;12(4):903-937. doi: 10.1007/s40122-023-00508-y. Epub 2023 May 25.
Chronic refractory low back and lower extremity pain recalcitrant to conservative management and epidural injections secondary to postsurgery syndrome, spinal stenosis, and disc herniation are sometimes managed with percutaneous adhesiolysis. Consequently, this systematic review and meta-analysis was undertaken to assess the efficacy of percutaneous adhesiolysis in managing low back and lower extremity pain.
A systematic review and meta-analysis of randomized controlled trials (RCTs) utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist was performed. A comprehensive literature search of multiple databases from 1966 to July 2022, including manual searches of the bibliography of known review articles was performed. Quality assessment of the included trials, meta-analysis, and best evidence synthesis was performed. The primary outcome measure was a significant reduction in pain (short term up to 6 months and long term more than 6 months).
The search identified 26 publications, with 9 trials meeting the inclusion criteria. The results of dual-arm and single-arm analyses showed significant improvement in pain and function at 12 months. Opioid consumption was also significantly reduced at 6 months with dual-arm analysis, whereas single-arm analysis showed a significant decrease from baseline to treatment at the 3-, 6-, and 12-month analyses. At 1 year follow-up, seven of seven trials were positive for improvements in pain relief, function, and diminution of opioid use.
Based on the present systematic review of nine RCTs, the evidence level is I to II, with moderate to strong recommendation for percutaneous adhesiolysis in managing low back and lower extremity pain. The limitations of the evidence include paucity of literature, lack of placebo-controlled trials, and the majority of the trials studying post lumbar surgery syndrome.
The evidence is level I to II or strong to moderate based on five high-quality and two moderate-quality RCTs, with 1 year follow-up that percutaneous adhesiolysis is efficacious in the treatment of chronic refractory low back and lower extremity pain.
慢性难治性腰腿痛对保守治疗及硬膜外注射均无效,继发于术后综合征、椎管狭窄和椎间盘突出症,有时采用经皮粘连松解术治疗。因此,进行了这项系统评价和荟萃分析,以评估经皮粘连松解术治疗腰腿痛和下肢疼痛的疗效。
采用系统评价和荟萃分析的首选报告项目(PRISMA)清单,对随机对照试验(RCT)进行系统评价和荟萃分析。对1966年至2022年7月的多个数据库进行了全面的文献检索,包括对已知综述文章的参考文献进行手工检索。对纳入试验进行质量评估、荟萃分析和最佳证据综合。主要结局指标是疼痛显著减轻(短期至6个月,长期超过6个月)。
检索到26篇文献,9项试验符合纳入标准。双臂和单臂分析结果显示,12个月时疼痛和功能有显著改善。双臂分析显示第6个月时阿片类药物的使用也显著减少,而单臂分析显示在第3、6和12个月分析时,从基线到治疗有显著下降。在1年随访时,7项试验中有7项在疼痛缓解、功能改善和阿片类药物使用减少方面呈阳性。
基于目前对9项RCT的系统评价,证据级别为I至II,对于经皮粘连松解术治疗腰腿痛和下肢疼痛有中度至强烈推荐。证据的局限性包括文献数量少、缺乏安慰剂对照试验,且大多数试验研究的是腰椎手术后综合征。
基于5项高质量和2项中等质量的RCT,随访1年的证据级别为I至II或强至中等,经皮粘连松解术治疗慢性难治性腰腿痛和下肢疼痛有效。